Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Praedicare
Dallas, Texas, United States
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Praedicare provides an AI- and math model–driven preclinical-to-clinical translation platform that has been used to run a virtual clinical trial for Mycobacterium avium complex lung disease, predicting superior efficacy and shorter treatment duration for ceftriaxone versus current standard of care and supporting progression to real patient trials[4]. The company focuses on de-risking and accelerating others’ pipelines rather than developing its own late-stage proprietary drugs[2][3][4].
- Therapeutic areas
- GastroenterologyOncologyInfectious Diseases
- Modalities
- Small moleculeBiologicVaccineRNA therapy
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on Praedicare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Praedicare.